tiprankstipranks
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
US Market
Holding MLTX?
Track your performance easily

MoonLake Immunotherapeutics (MLTX) Cash flow

299 Followers

MoonLake Immunotherapeutics Cash Flow

MLTX's free cash flow for Q3 2024 was $-25.41M. For the 2024 fiscal year, MLTX's free cash flow was decreased by $12.85M and operating cash flow was $-25.27M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -80.46M$ -42.78M$ -55.89M$ -611.07K$ -316.69K
Investing Cash Flow
$ 58.60M$ -25.18M$ -32.34M-$ -115.00M
Financing Cash Flow
$ 79.58M$ 479.70M$ 119.69M$ -58.06K$ 116.65M
Cash Flow From Discontinued Operation
-----
Other Cash Adjustment Inside Changein Cash
-----
End Cash Position
$ 1.63B$ 451.17M$ 39.51M$ 666.79K$ 1.34M
Income Tax Paid Supplemental Data
$ 41.71K$ 41.71K$ 4.31K--
Interest Paid Supplemental Data
-----
Issuance Of Capital Stock
$ 83.71M$ 482.45M--$ 4.30M
Issuance Of Debt
--$ -15.00M$ -58.06K-
Repayment Of Debt
--$ -15.00M$ -58.06K-
Free Cash Flow
$ -68.46M$ -43.06M$ -55.91M$ -611.07K$ -316.69K
Domestic Sales
-----
Foreign Sales
-----
Currency in USD

MoonLake Immunotherapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis